02:47 PM EDT, 06/10/2025 (MT Newswires) -- Biohaven ( BHVN ) has entered a multi-program research collaboration with Bexorg to advance next-generation therapies for central nervous system disorders, Bexorg said Tuesday.

Financial details weren't disclosed.

As part of the collaboration, Bexorg will apply its proprietary whole-brain discovery platform to support two of Biohaven's ( BHVN ) preclinical development programs, with an aim to generate detailed insights into target engagement, pharmacokinetics, pharmacodynamics, and mechanisms of action for Biohaven's ( BHVN ) investigational therapies.

Price: 16.92, Change: -0.14, Percent Change: -0.81